Substrate specificity of the ubiquitin and Ubl proteases

Cell Research

Volumn 26, Issue 4, 2016, Pages 441-456

  Ronau, Judith A ^a   Beckmann, John F ^a   Hochstrasser, Mark ^a  

^a YALE UNIVERSITY   (United States)

Author keywords

DUBs; Nedd8; SUMO; ubiquitin; Ubl proteases; ULPs

Indexed keywords

DEUBIQUITINASE; UBIQUITIN;

CHEMISTRY; ENZYME ACTIVE SITE; ENZYME SPECIFICITY; HUMAN; METABOLISM; PROTEIN CONFORMATION; STRUCTURE ACTIVITY RELATION;

CATALYTIC DOMAIN; DEUBIQUITINATING ENZYMES; HUMANS; PROTEIN CONFORMATION; STRUCTURE-ACTIVITY RELATIONSHIP; SUBSTRATE SPECIFICITY; UBIQUITIN; UBIQUITINS;

EID: 84961757578     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2016.38     Document Type: Review

References (150)

1. Glickman MH, Ciechanover A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev 2002; 82:373-428.
2. Hershko A, Ciechanover A. The ubiquitin system. Annu Rev Biochem 1998; 67:425-479.
3. Komander D, Rape M. The ubiquitin code. Annu Rev Biochem 2012; 81:203-229.
4. Varshavsky A. The ubiquitin system. Trends Biochem Sci 1997; 22:383-387.
5. Pickart CM, Eddins MJ. Ubiquitin: structures, functions, mechanisms. Biochim Biophys Acta 2004; 1695:55-72.
6. Schulman BA, Harper JW. Ubiquitin-like protein activation by E1 enzymes: the apex for downstream signalling pathways. Nat Rev Mol Cell Biol 2009; 10:319-331.
7. Haglund K, Dikic I. Ubiquitylation and cell signaling. EMBO J 2005; 24:3353-3359.
8. Ikeda F, Dikic I. Atypical ubiquitin chains: new molecular signals. 'Protein Modifications: Beyond the Usual Suspects' review series. EMBO Rep 2008; 9:536-542.
9. Pickart CM. Ubiquitin in chains. Trends Biochem Sci 2000; 25:544-548.
10. Ben-Saadon R, Zaaroor D, Ziv T, Ciechanover A. The polycomb protein Ring1B generates self atypical mixed ubiquitin chains required for its in vitro histone H2A ligase activity. Mol Cell 2006; 24:701-711.
11. Boname JM, Thomas M, Stagg HR, Xu P, Peng J, Lehner PJ. Efficient internalization of MHC I requires lysine-11 and lysine-63 mixed linkage polyubiquitin chains. Traffic 2010; 11:210-220.
12. Kravtsova-Ivantsiv Y, Ciechanover A. Non-canonical ubiquitin-based signals for proteasomal degradation. J Cell Sci 2012; 125:539-548.
13. Newton K, Matsumoto ML, Wertz IE, et al. Ubiquitin chain editing revealed by polyubiquitin linkage-specific antibodies. Cell 2008; 134:668-678.
14. Hochstrasser M. Origin and function of ubiquitin-like proteins. Nature 2009; 458:422-429.
15. Schulman BA. Twists and turns in ubiquitin-like protein conjugation cascades. Protein Sci 2011; 20:1941-1954.
16. Hickey CM, Wilson NR, Hochstrasser M. Function and regulation of SUMO proteases. Nat Rev Mol Cell Biol 2012; 13:755-766.
17. Guzzo CM, Matunis MJ. Expanding SUMO and ubiquitin-mediated signaling through hybrid SUMO-ubiquitin chains and their receptors. Cell Cycle 2013; 12:1015-1017.
18. Amerik AY, Hochstrasser M. Mechanism and function of deubiquitinating enzymes. Biochim Biophys Acta 2004; 1695:189-207.
19. Komander D. Mechanism, specificity and structure of the deubiquitinases. Subcell Biochem 2010; 54:69-87.
20. Komander D, Clague MJ, Urbe S. Breaking the chains: structure and function of the deubiquitinases. Nat Rev Mol Cell Biol 2009; 10:550-563.
21. Nijman SM, Luna-Vargas MP, Velds A, et al. A genomic and functional inventory of deubiquitinating enzymes. Cell 2005; 123:773-786.
22. Beal R, Deveraux Q, Xia G, Rechsteiner M, Pickart C. Surface hydrophobic residues of multiubiquitin chains essential for proteolytic targeting. Proc Natl Acad Sci USA 1996; 93:861-866.
23. Sloper-Mould KE, Jemc JC, Pickart CM, Hicke L. Distinct functional surface regions on ubiquitin. J Biol Chem 2001; 276:30483-30489.
24. Reverter D, Wu K, Erdene TG, Pan ZQ, Wilkinson KD, Lima CD. Structure of a complex between Nedd8 and the Ulp/Senp protease family member Den1. J Mol Biol 2005; 345:141-151.
25. Shen LN, Liu H, Dong C, Xirodimas D, Naismith JH, Hay RT. Structural basis of NEDD8 ubiquitin discrimination by the deNEDDylating enzyme NEDP1. EMBO J 2005; 24:1341-1351.
26. Sheedlo MJ, Qiu J, Tan Y, Paul LN, Luo ZQ, Das C. Structural basis of substrate recognition by a bacterial deubiquitinase important for dynamics of phagosome ubiquitination. Proc Natl Acad Sci USA 2015; 112:15090-15095.
27. Sato Y, Goto E, Shibata Y, et al. Structures of CYLD USP with Met1-or Lys63-linked diubiquitin reveal mechanisms for dual specificity. Nat Struct Mol Biol 2015; 22:222-229.
28. Hu M, Li P, Li M, et al. Crystal structure of a UBP-family deubiquitinating enzyme in isolation and in complex with ubiquitin aldehyde. Cell 2002; 111:1041-1054.
29. Lange OF, Lakomek NA, Fares C, et al. Recognition dynamics up to microseconds revealed from an RDC-derived ubiquitin ensemble in solution. Science 2008; 320:1471-1475.
30. Ye Y, Akutsu M, Reyes-Turcu F, Enchev RI, Wilkinson KD, Komander D. Polyubiquitin binding and cross-reactivity in the USP domain deubiquitinase USP21. EMBO Rep 2011; 12:350-357.
31. Vijay-Kumar S, Bugg CE, Cook WJ. Structure of ubiquitin refined at 1.8 Å resolution. J Mol Biol 1987; 194:531-544.
32. Morrow ME, Kim MI, Ronau JA, et al. Stabilization of an unusual salt bridge in ubiquitin by the extra C-terminal domain of the proteasome-associated deubiquitinase UCH37 as a mechanism of its exo specificity. Biochemistry 2013; 52:3564-3578.
33. Sato Y, Yoshikawa A, Yamagata A, et al. Structural basis for specific cleavage of Lys 63-linked polyubiquitin chains. Nature 2008; 455:358-362.
34. Cappadocia L, Pichler A, Lima CD. Structural basis for catalytic activation by the human ZNF451 SUMO E3 ligase. Nat Struct Mol Biol 2015; 22:968-975.
35. Reverter D, Lima CD. A basis for SUMO protease specificity provided by analysis of human Senp2 and a Senp2-SUMO complex. Structure 2004; 12:1519-1531.
36. Reverter D, Lima CD. Structural basis for SENP2 protease interactions with SUMO precursors and conjugated substrates. Nat Struct Mol Biol 2006; 13:1060-1068.
37. Phillips AH, Zhang Y, Cunningham CN, et al. Conformational dynamics control ubiquitin-deubiquitinase interactions and influence in vivo signaling. Proc Natl Acad Sci USA 2013; 110:11379-11384.
38. Kazlauskaite A, Kondapalli C, Gourlay R, et al. Parkin is activated by PINK1-dependent phosphorylation of ubiquitin at Ser65. Biochem J 2014; 460:127-139.
39. Koyano F, Okatsu K, Kosako H, et al. Ubiquitin is phosphorylated by PINK1 to activate parkin. Nature 2014; 510:162-166.
40. Swaney DL, Beltrao P, Starita L, et al. Global analysis of phosphorylation and ubiquitylation cross-talk in protein degradation. Nat Methods 2013; 10:676-682.
41. Wauer T, Swatek KN, Wagstaff JL, et al. Ubiquitin Ser65 phosphorylation affects ubiquitin structure, chain assembly and hydrolysis. EMBO J 2015; 34:307-325.
42. Swaney DL, Rodriguez-Mias RA, Villen J. Phosphorylation of ubiquitin at Ser65 affects its polymerization, targets, and proteome-wide turnover. EMBO Rep 2015; 16:1131-1144.
43. Datta AB, Hura GL, Wolberger C. The structure and conformation of Lys63-linked tetraubiquitin. J Mol Biol 2009; 392:1117-1124.
44. Weeks SD, Grasty KC, Hernandez-Cuebas L, Loll PJ. Crystal structures of Lys-63-linked tri-and di-ubiquitin reveal a highly extended chain architecture. Proteins 2009; 77:753-759.
45. Komander D, Reyes-Turcu F, Licchesi JD, Odenwaelder P, Wilkinson KD, Barford D. Molecular discrimination of structurally equivalent Lys 63-linked and linear polyubiquitin chains. EMBO Rep 2009; 10:466-473.
46. Cook WJ, Jeffrey LC, Carson M, Chen Z, Pickart CM. Structure of a diubiquitin conjugate and a model for interaction with ubiquitin conjugating enzyme (E2). J Biol Chem 1992; 267:16467-16471.
47. Eddins MJ, Varadan R, Fushman D, Pickart CM, Wolberger C. Crystal structure and solution NMR studies of Lys48-linked tetraubiquitin at neutral pH. J Mol Biol 2007; 367:204-211.
48. Bremm A, Freund SM, Komander D. Lys11-linked ubiquitin chains adopt compact conformations and are preferentially hydrolyzed by the deubiquitinase Cezanne. Nat Struct Mol Biol 2010; 17:939-947.
49. Hospenthal MK, Freund SM, Komander D. Assembly, analysis and architecture of atypical ubiquitin chains. Nat Struct Mol Biol 2013; 20:555-565.
50. Matsumoto ML, Wickliffe KE, Dong KC, et al. K11-linked polyubiquitination in cell cycle control revealed by a K11 linkage-specific antibody. Mol Cell 2010; 39:477-484.
51. Kristariyanto YA, Choi SY, Rehman SA, et al. Assembly and structure of Lys33-linked polyubiquitin reveals distinct conformations. Biochem J 2015; 467:345-352.
52. Hirano T, Serve O, Yagi-Utsumi M, et al. Conformational dynamics of wild-type Lys-48-linked diubiquitin in solution. J Biol Chem 2011; 286:37496-37502.
53. Rohaim A, Kawasaki M, Kato R, Dikic I, Wakatsuki S. Structure of a compact conformation of linear diubiquitin. Acta Crystallogr D Biol Crystallogr 2012; 68:102-108.
54. Cooper EM, Cutcliffe C, Kristiansen TZ, Pandey A, Pickart CM, Cohen RE. K63-specific deubiquitination by two JAMM/ MPN+ complexes: BRISC-associated Brcc36 and proteasomal Poh1. EMBO J 2009; 28:621-631.
55. Ritorto MS, Ewan R, Perez-Oliva AB, et al. Screening of DUB activity and specificity by MALDI-TOF mass spectrometry. Nat Commun 2014; 5:4763.
56. Davies CW, Paul LN, Kim MI, Das C. Structural and thermodynamic comparison of the catalytic domain of AMSH and AMSH-LP: nearly identical fold but different stability. J Mol Biol 2011; 413:416-429.
57. Faesen AC, Luna-Vargas MP, Geurink PP, et al. The differential modulation of USP activity by internal regulatory domains, interactors and eight ubiquitin chain types. Chem Biol 2011; 18:1550-1561.
58. Mevissen TE, Hospenthal MK, Geurink PP, et al. OTU deubiquitinases reveal mechanisms of linkage specificity and enable ubiquitin chain restriction analysis. Cell 2013; 154:169-184.
59. Messick TE, Russell NS, Iwata AJ, et al. Structural basis for ubiquitin recognition by the Otu1 ovarian tumor domain protein. J Biol Chem 2008; 283:11038-11049.
60. Das C, Hoang QQ, Kreinbring CA, et al. Structural basis for conformational plasticity of the Parkinson's disease-associated ubiquitin hydrolase UCH-L1. Proc Natl Acad Sci USA 2006; 103:4675-4680.
61. Edelmann MJ, Iphofer A, Akutsu M, et al. Structural basis and specificity of human otubain 1-mediated deubiquitination. Biochem J 2009; 418:379-390.
62. Johnston SC, Riddle SM, Cohen RE, Hill CP. Structural basis for the specificity of ubiquitin C-terminal hydrolases. EMBO J 1999; 18:3877-3887.
63. Keusekotten K, Elliott PR, Glockner L, et al. OTULIN antagonizes LUBAC signaling by specifically hydrolyzing Met1-linked polyubiquitin. Cell 2013; 153:1312-1326.
64. Maiti TK, Permaul M, Boudreaux DA, Mahanic C, Mauney S, Das C. Crystal structure of the catalytic domain of UCHL5, a proteasome-associated human deubiquitinating enzyme, reveals an unproductive form of the enzyme. FEBS J 2011; 278:4917-4926.
65. Boudreaux DA, Maiti TK, Davies CW, Das C. Ubiquitin vinyl methyl ester binding orients the misaligned active site of the ubiquitin hydrolase UCHL1 into productive conformation. Proc Natl Acad Sci USA 2010; 107:9117-9122.
66. Sahtoe DD, van Dijk WJ, El Oualid F, Ekkebus R, Ovaa H, Sixma TK. Mechanism of UCH-L5 activation and inhibition by DEUBAD domains in RPN13 and INO80G. Mol Cell 2015; 57:887-900.
67. VanderLinden RT, Hemmis CW, Schmitt B, et al. Structural basis for the activation and inhibition of the UCH37 deubiquitylase. Mol Cell 2015; 57:901-911.
68. Reyes-Turcu FE, Ventii KH, Wilkinson KD. Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes. Annu Rev Biochem 2009; 78:363-397.
69. Hibi K, Liu Q, Beaudry GA, et al. Serial analysis of gene expression in non-small cell lung cancer. Cancer Res 1998; 58:5690-5694.
70. Leroy E, Boyer R, Auburger G, et al. The ubiquitin pathway in Parkinson's disease. Nature 1998; 395:451-452.
71. Fiil BK, Damgaard RB, Wagner SA, et al. OTULIN restricts Met1-linked ubiquitination to control innate immune signaling. Mol Cell 2013; 50:818-830.
72. Rivkin E, Almeida SM, Ceccarelli DF, et al. The linear ubiquitin-specific deubiquitinase gumby regulates angiogenesis. Nature 2013; 498:318-324.
73. Komander D, Lord CJ, Scheel H, et al. The structure of the CYLD USP domain explains its specificity for Lys63-linked polyubiquitin and reveals a B box module. Mol Cell 2008; 29:451-464.
74. Mossessova E, Lima CD. Ulp1-SUMO crystal structure and genetic analysis reveal conserved interactions and a regulatory element essential for cell growth in yeast. Mol Cell 2000; 5:865-876.
75. Shen LN, Dong C, Liu H, Naismith JH, Hay RT. The structure of SENP1-SUMO-2 complex suggests a structural basis for discrimination between SUMO paralogues during processing. Biochem J 2006; 397:279-288.
76. Xu Z, Chau SF, Lam KH, Chan HY, Ng TB, Au SW. Crystal structure of the SENP1 mutant C603S-SUMO complex reveals the hydrolytic mechanism of SUMO-specific protease. Biochem J 2006; 398:345-352.
77. Kulathu Y, Komander D. Atypical ubiquitylation - the unexplored world of polyubiquitin beyond Lys48 and Lys63 linkages. Nat Rev Mol Cell Biol 2012; 13:508-523.
78. Wolberger C. Mechanisms for regulating deubiquitinating enzymes. Protein Sci 2014; 23:344-353.
79. Xu Z, Lam LS, Lam LH, Chau SF, Ng TB, Au SW. Molecular basis of the redox regulation of SUMO proteases: a protective mechanism of intermolecular disulfide linkage against irreversible sulfhydryl oxidation. FASEB J 2008; 22:127-137.
80. Holmstrom KM, Finkel T. Cellular mechanisms and physiological consequences of redox-dependent signalling. Nat Rev Mol Cell Biol 2014; 15:411-421.
81. Cotto-Rios XM, Bekes M, Chapman J, Ueberheide B, Huang TT. Deubiquitinases as a signaling target of oxidative stress. Cell Rep 2012; 2:1475-1484.
82. Lee JG, Baek K, Soetandyo N, Ye Y. Reversible inactivation of deubiquitinases by reactive oxygen species in vitro and in cells. Nat Commun 2013; 4:1568.
83. Scherz-Shouval R, Shvets E, Fass E, Shorer H, Gil L, Elazar Z. Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4. EMBO J 2007; 26:1749-1760.
84. Zhou ZR, Zhang YH, Liu S, Song AX, Hu HY. Length of the active-site crossover loop defines the substrate specificity of ubiquitin C-terminal hydrolases for ubiquitin chains. Biochem J 2012; 441:143-149.
85. Artavanis-Tsakonas K, Weihofen WA, Antos JM, et al. Characterization and structural studies of the Plasmodium falciparum ubiquitin and Nedd8 hydrolase UCHL3. J Biol Chem 2010; 285:6857-6866.
86. Burgie SE, Bingman CA, Soni AB, Phillips GN Jr. Structural characterization of human Uch37. Proteins 2012; 80:649-654.
87. Misaghi S, Galardy PJ, Meester WJ, Ovaa H, Ploegh HL, Gaudet R. Structure of the ubiquitin hydrolase UCH-L3 complexed with a suicide substrate. J Biol Chem 2005; 280:1512-1520.
88. Scheuermann JC, de Ayala Alonso AG, Oktaba K, et al. Histone H2A deubiquitinase activity of the Polycomb repressive complex PR-DUB. Nature 2010; 465:243-247.
89. Yao T, Song L, Xu W, et al. Proteasome recruitment and activation of the Uch37 deubiquitinating enzyme by Adrm1. Nat Cell Biol 2006; 8:994-1002.
90. Larsen CN, Krantz BA, Wilkinson KD. Substrate specificity of deubiquitinating enzymes: ubiquitin C-terminal hydrolases. Biochemistry 1998; 37:3358-3368.
91. Popp MW, Artavanis-Tsakonas K, Ploegh HL. Substrate filtering by the active site crossover loop in UCHL3 revealed by sortagging and gain-of-function mutations. J Biol Chem 2009; 284:3593-3602.
92. Sahtoe DD, van Dijk WJ, Ekkebus R, Ovaa H, Sixma TK. BAP1/ASXL1 recruitment and activation for H2A deubiquitination. Nat Commun 2016; 7:10292.
93. Ambroggio XI, Rees DC, Deshaies RJ. JAMM: a metalloprotease-like zinc site in the proteasome and signalosome. PLoS Biol 2004; 2:E2.
94. Verma R, Aravind L, Oania R, et al. Role of Rpn11 metalloprotease in deubiquitination and degradation by the 26S proteasome. Science 2002; 298:611-615.
95. Birol M, Echalier A. Structure and function of MPN (Mpr1/ Pad1 N-terminal) domain-containing proteins. Curr Protein Pept Sci 2014; 15:504-517.
96. Echalier A, Pan Y, Birol M, et al. Insights into the regulation of the human COP9 signalosome catalytic subunit, CSN5/ Jab1. Proc Natl Acad Sci USA 2013; 110:1273-1278.
97. Guterman A, Glickman MH. Deubiquitinating enzymes are IN/(trinsic to proteasome function). Curr Protein Pept Sci 2004; 5:201-211.
98. Kyuuma M, Kikuchi K, Kojima K, et al. AMSH, an ESCRT-III associated enzyme, deubiquitinates cargo on MVB/ late endosomes. Cell Struct Funct 2007; 31:159-172.
99. Lingaraju GM, Bunker RD, Cavadini S, et al. Crystal structure of the human COP9 signalosome. Nature 2014; 512:161-165.
100. Sobhian B, Shao G, Lilli DR, et al. RAP80 targets BRCA1 to specific ubiquitin structures at DNA damage sites. Science 2007; 316:1198-1202.
101. Yao T, Cohen RE. A cryptic protease couples deubiquitination and degradation by the proteasome. Nature 2002; 419:403-407.
102. McCullough J, Row PE, Lorenzo O, et al. Activation of the endosome-associated ubiquitin isopeptidase AMSH by STAM, a component of the multivesicular body-sorting machinery. Curr Biol 2006; 16:160-165.
103. Shrestha RK, Ronau JA, Davies CW, et al. Insights into the mechanism of deubiquitination by JAMM deubiquitinases from cocrystal structures of the enzyme with the substrate and product. Biochemistry 2014; 53:3199-3217.
104. Bueno AN, Shrestha RK, Ronau JA, et al. Dynamics of an active-site flap contributes to catalysis in a JAMM family metallo deubiquitinase. Biochemistry 2015; 54:6038-6051.
105. Davies CW, Paul LN, Das C. Mechanism of recruitment and activation of the endosome-associated deubiquitinase AMSH. Biochemistry 2013; 52:7818-7829.
106. Kim MS, Kim JA, Song HK, Jeon H. STAM-AMSH interaction facilitates the deubiquitination activity in the C-terminal AMSH. Biochem Biophys Res Commun 2006; 351:612-618.
107. Wei N, Deng XW. The COP9 signalosome. Annu Rev Cell Dev Biol 2003; 19:261-286.
108. Lyapina S, Cope G, Shevchenko A, et al. Promotion of NEDD-CUL1 conjugate cleavage by COP9 signalosome. Science 2001; 292:1382-1385.
109. Schwechheimer C, Serino G, Callis J, et al. Interactions of the COP9 signalosome with the E3 ubiquitin ligase SCFTIRI in mediating auxin response. Science 2001; 292:1379-1382.
110. Cope GA, Suh GS, Aravind L, et al. Role of predicted metalloprotease motif of Jab1/Csn5 in cleavage of Nedd8 from Cul1. Science 2002; 298:608-611.
111. Sharon M, Mao H, Boeri Erba E, Stephens E, Zheng N, Robinson CV. Symmetrical modularity of the COP9 signalosome complex suggests its multifunctionality. Structure 2009; 17:31-40.
112. Tomko RJ Jr, Hochstrasser M. Molecular architecture and assembly of the eukaryotic proteasome. Annu Rev Biochem 2013; 82:415-445.
113. Tomko RJ Jr, Taylor DW, Chen ZA, Wang HW, Rappsilber J, Hochstrasser M. A single alpha helix drives extensive remodeling of the proteasome lid and completion of regulatory particle assembly. Cell 2015; 163:432-444.
114. Mansour W, Nakasone MA, von Delbruck M, et al. Disassembly of Lys11 and mixed linkage polyubiquitin conjugates provides insights into function of proteasomal deubiquitinases Rpn11 and Ubp6. J Biol Chem 2015; 290:4688-4704.
115. Pathare GR, Nagy I, Sledz P, et al. Crystal structure of the proteasomal deubiquitylation module Rpn8-Rpn11. Proc Natl Acad Sci USA 2014; 111:2984-2989.
116. Worden EJ, Padovani C, Martin A. Structure of the Rpn11-Rpn8 dimer reveals mechanisms of substrate deubiquitination during proteasomal degradation. Nat Struct Mol Biol 2014; 21:220-227.
117. Dambacher CM, Worden EJ, Herzik MA, Martin A, Lander GC. Atomic structure of the 26S proteasome lid reveals the mechanism of deubiquitinase inhibition. Elife 2016; 5:e13027.
118. Ye Y, Scheel H, Hofmann K, Komander D. Dissection of USP catalytic domains reveals five common insertion points. Mol Biosyst 2009; 5:1797-1808.
119. Lima CD, Reverter D. Structure of the human SENP7 catalytic domain and poly-SUMO deconjugation activities for SENP6 and SENP7. J Biol Chem 2008; 283:32045-32055.
120. Alegre KO, Reverter D. Structural insights into the SENP6 Loop1 structure in complex with SUMO2. Protein Sci 2014; 23:433-441.
121. Hepowit NL, Uthandi S, Miranda HV, et al. Archaeal JAB1/ MPN/MOV34 metalloenzyme (HvJAMM1) cleaves ubiquitin-like small archaeal modifier proteins (SAMPs) from protein-conjugates. Mol Microbiol 2012; 86:971-987.
122. Balakirev MY, Jaquinod M, Haas AL, Chroboczek J. Deubiquitinating function of adenovirus proteinase. J Virol 2002; 76:6323-6331.
123. Perrett CA, Lin DY, Zhou D. Interactions of bacterial proteins with host eukaryotic ubiquitin pathways. Front Microbiol 2011; 2:143.
124. Beckmann JF, Fallon AM. Detection of the Wolbachia protein WPIP0282 in mosquito spermathecae: implications for cytoplasmic incompatibility. Insect Biochem Mol Biol 2013; 43:867-878.
125. Catic A, Misaghi S, Korbel GA, Ploegh HL. ElaD, a deubiquitinating protease expressed by E. coli. PLoS One 2007; 2:e381.
126. Li SJ, Hochstrasser M. A new protease required for cell-cycle progression in yeast. Nature 1999; 398:246-251.
127. Bardill JP, Miller JL, Vogel JP. IcmS-dependent translocation of SdeA into macrophages by the Legionella pneumophila type IV secretion system. Mol Microbiol 2005; 56:90-103.
128. Furtado AR, Essid M, Perrinet S, et al. The chlamydial OTU domain-containing protein ChlaOTU is an early type III secretion effector targeting ubiquitin and NDP52. Cell Microbiol 2013; 15:2064-2079.
129. Hotson A, Chosed R, Shu H, Orth K, Mudgett MB. Xanthomonas type III effector XopD targets SUMO-conjugated proteins in planta. Mol Microbiol 2003; 50:377-389.
130. Claessen JH, Witte MD, Yoder NC, Zhu AY, Spooner E, Ploegh HL. Catch-and-release probes applied to semi-intact cells reveal ubiquitin-specific protease expression in Chlamydia trachomatis infection. Chembiochem 2013; 14:343-352.
131. Misaghi S, Balsara ZR, Catic A, Spooner E, Ploegh HL, Starnbach MN. Chlamydia trachomatis-derived deubiquitinating enzymes in mammalian cells during infection. Mol Microbiol 2006; 61:142-150.
132. Penz T, Schmitz-Esser S, Kelly SE, et al. Comparative genomics suggests an independent origin of cytoplasmic incompatibility in Cardinium hertigii. PLoS Genet 2012; 8:e1003012.
133. Havey JC, Roy CR. Toxicity and SidJ-mediated suppression of toxicity require distinct regions in the SidE family of Legionella pneumophila effectors. Infect Immun 2015; 83:3506-3514.
134. Rytkonen A, Poh J, Garmendia J, et al. SseL, a Salmonella deubiquitinase required for macrophage killing and virulence. Proc Natl Acad Sci USA 2007; 104:3502-3507.
135. Noel L, Thieme F, Nennstiel D, Bonas U. Two novel type III-secreted proteins of Xanthomonas campestris pv. Vesicatoria are encoded within the hrp pathogenicity island. J Bacteriol 2002; 184:1340-1348.
136. Schlieker C, Korbel GA, Kattenhorn LM, Ploegh HL. A deubiquitinating activity is conserved in the large tegument protein of the herpesviridae. J Virol 2005; 79:15582-15585.
137. Chenon M, Camborde L, Cheminant S, Jupin I. A viral deubiquitylating enzyme targets viral RNA-dependent RNA polymerase and affects viral infectivity. EMBO J 2012; 31:741-753.
138. Chosed R, Tomchick DR, Brautigam CA, et al. Structural analysis of Xanthomonas XopD provides insights into substrate specificity of ubiquitin-like protein proteases. J Biol Chem 2007; 282:6773-6782.
139. McGrath WJ, Ding J, Didwania A, Sweet RM, Mangel WF. Crystallographic structure at 1.6-Å resolution of the human adenovirus proteinase in a covalent complex with its 11-amino-acid peptide cofactor: insights on a new fold. Biochim Biophys Acta 2003; 1648:1-11.
140. Mangel WF, Baniecki ML, McGrath WJ. Specific interactions of the adenovirus proteinase with the viral DNA, an 11-amino-acid viral peptide, and the cellular protein actin. Cell Mol Life Sci 2003; 60:2347-2355.
141. Mangel WF, McGrath WJ, Toledo DL, Anderson CW. Viral DNA and a viral peptide can act as cofactors of adenovirus virion proteinase activity. Nature 1993; 361:274-275.
142. Frias-Staheli N, Giannakopoulos NV, Kikkert M, et al. Ovarian tumor domain-containing viral proteases evade ubiquitinand ISG15-dependent innate immune responses. Cell Host Microbe 2007; 2:404-416.
143. Akutsu M, Ye Y, Virdee S, Chin JW, Komander D. Molecular basis for ubiquitin and ISG15 cross-reactivity in viral ovarian tumor domains. Proc Natl Acad Sci USA 2011; 108:2228-2233.
144. James TW, Frias-Staheli N, Bacik JP, et al. Structural basis for the removal of ubiquitin and interferon-stimulated gene 15 by a viral ovarian tumor domain-containing protease. Proc Natl Acad Sci USA 2011; 108:2222-2227.
145. van Kasteren PB, Bailey-Elkin BA, James TW, et al. Deubiquitinase function of arterivirus papain-like protease 2 suppresses the innate immune response in infected host cells. Proc Natl Acad Sci USA 2013; 110:E838-847.
146. Whitby FG, Xia G, Pickart CM, Hill CP. Crystal structure of the human ubiquitin-like protein NEDD8 and interactions with ubiquitin pathway enzymes. J Biol Chem 1998; 273:34983-34991.
147. Huang WC, Ko TP, Li SS, Wang AH. Crystal structures of the human SUMO-2 protein at 1.6 Å and 1.2 Å resolution: implication on the functional differences of SUMO proteins. Eur J Biochem 2004; 271:4114-4122.
148. Narasimhan J, Wang M, Fu Z, Klein JM, Haas AL, Kim JJ. Crystal structure of the interferon-induced ubiquitin-like protein ISG15. J Biol Chem 2005; 280:27356-27365.
149. Kumeta H, Watanabe M, Nakatogawa H, et al. The NMR structure of the autophagy-related protein Atg8. J Biomol NMR 2010; 47:237-241.
150. Johnston SC, Larsen CN, Cook WJ, Wilkinson KD, Hill CP. Crystal structure of a deubiquitinating enzyme (human UCH-L3) at 1.8 A resolution. EMBO J 1997; 16:3787-3796.